Silo Pharma Inc
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's … Read more
Silo Pharma Inc (SILO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.191x
Based on the latest financial reports, Silo Pharma Inc (SILO) has a cash flow conversion efficiency ratio of -0.191x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-955.49K) by net assets ($5.01 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Silo Pharma Inc - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Silo Pharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Silo Pharma Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Silo Pharma Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
National Stock Yards Co
PINK:NSYC
|
N/A |
|
KOAS Co. Ltd
KO:071950
|
0.001x |
|
STENOCARE DK-08
F:S7C
|
N/A |
|
Petrolympic Ltd
PINK:PCQRF
|
0.013x |
|
ADM Endeavors Inc
OTCQB:ADMQ
|
0.114x |
|
Credit Intelligence Ltd
AU:CI1
|
0.066x |
|
AMERIPRISE FINCL (A4S.SG)
STU:A4S
|
0.533x |
|
ExGen Resources Inc
PINK:BXXRF
|
-0.168x |
Annual Cash Flow Conversion Efficiency for Silo Pharma Inc (2011–2024)
The table below shows the annual cash flow conversion efficiency of Silo Pharma Inc from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $5.03 Million | $-3.83 Million | -0.762x | -45.89% |
| 2023-12-31 | $6.18 Million | $-3.22 Million | -0.522x | -54.34% |
| 2022-12-31 | $10.34 Million | $-3.50 Million | -0.338x | -34.55% |
| 2021-12-31 | $9.06 Million | $-2.28 Million | -0.251x | +72.18% |
| 2020-12-31 | $1.28 Million | $-1.16 Million | -0.903x | -102.60% |
| 2019-12-31 | $-22.89K | $-794.32K | 34.699x | +5085.55% |
| 2018-12-31 | $407.44K | $272.64K | 0.669x | +382.84% |
| 2017-12-31 | $1.20 Million | $-284.62K | -0.237x | -39.51% |
| 2016-12-31 | $846.51K | $-143.56K | -0.170x | +67.32% |
| 2015-12-31 | $1.96 Million | $-1.02 Million | -0.519x | -15.64% |
| 2014-12-31 | $2.37 Million | $-1.06 Million | -0.449x | -341.92% |
| 2013-12-31 | $1.79 Million | $-181.61K | -0.102x | -119.48% |
| 2012-12-31 | $-41.19K | $-21.47K | 0.521x | -98.03% |
| 2011-12-31 | $-1.75K | $-46.30K | 26.489x | -- |